• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • EMBELIN
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION AND STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION AND AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • DOPAMINE AND ADDICTION
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • FASTING BRAIN
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS
      • STREPTOCOCCUS MUTANS
      • STRESS AGING
      • STRESS BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    SIRT1
    February 2, 2022
    MEDITERRANEAN DIET
    February 2, 2022
    1. Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats
    2. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients
    3. Advances in our understanding of oxylipins derived from dietary PUFAs
    4. N-3 polyunsaturated fatty acids (PUFAs) reverse the impact of early-life stress on the gut microbiota
    5. Recent findings of long-chain n-3 polyunsaturated fatty acids (LCn-3 PUFAs) on atherosclerosis and coronary heart disease (CHD) contrasting studies in Western …
    6. Significance of long-chain polyunsaturated fatty acids (PUFAs) for the development and behaviour of children
    7. Potential roles of n-3 PUFAs during skeletal muscle growth and regeneration
    8. Efficacy of omega-3 PUFAs in depression: a meta-analysis
    9. Thraustochytrid marine protists: production of PUFAs and other emerging technologies
    10. Does supplementation with omega-3 PUFAs add to the prevention of cardiovascular disease?
    11. Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes
    12. Cox-2 expression, PGE2 and cytokines production are inhibited by endogenously synthesized n-3 PUFAs in inflamed colon of fat-1 mice
    13. Dietary n-3 PUFAs deficiency increases vulnerability to inflammation-induced spatial memory impairment
    14. PUFAs: structures, metabolism and functions
    15. PUFAs in fish: extraction, fractionation, importance in health
    16. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system
    17. Retinal very long-chain PUFAs: new insights from studies on ELOVL4 protein
    18. Omega− 3 Polyunsaturated Fatty Acids (PUFAs): Emerging Plant and Microbial Sources, Oxidative Stability, Bioavailability, and Health Benefits—A Review
    19. The anti-inflammatory and antioxidant properties of n-3 PUFAs: Their role in cardiovascular protection
    20. Advances in microencapsulation of polyunsaturated fatty acids (PUFAs)-rich plant oils using complex coacervation: A review
    21. Effects of fish n-3 PUFAs on intestinal microbiota and immune system
    22. Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil
    23. Microbial sources of polyunsaturated fatty acids (PUFAs) and the prospect of organic residues and wastes as growth media for PUFA-producing microorganisms
    24. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
    25. n-3 PUFAs modulate T-cell activation via protein kinase C-α and-ε and the NF-κB signaling pathway
    26. A novel anti-inflammatory role of omega-3 PUFAs in prevention and treatment of atherosclerosis and vascular cognitive impairment and dementia
    27. Long-term supplementation with n-6 and n-3 PUFAs improves moderate-to-severe keratoconjunctivitis sicca: a randomized double-blind clinical trial
    28. Role of soluble epoxide hydrolase in metabolism of PUFAs in psychiatric and neurological disorders
    29. Daily supplementation with (n-3) PUFAs, oleic acid, folic acid, and vitamins B-6 and E increases pain-free walking distance and improves risk factors in men with …
    30. G-protein-coupled receptors mediate ω-3 PUFAs-inhibited colorectal cancer by activating the Hippo pathway
    31. Do ω-3 PUFAs affect insulin resistance in a sex-specific manner? A systematic review and meta-analysis of randomized controlled trials
    32. Intakes of long-chain omega-3 (n− 3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study
    33. Long-chain n− 3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial
    34. PUFAs, bone mineral density, and fragility fracture: findings from human studies
    35. The Physiological Effect of n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Intake and Exercise on Hemorheology, Microvascular Function, and Physical …
    36. Omega-3 PUFAs lower the propensity for arachidonic acid cascade overreactions
    37. ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation
    38. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and …
    39. Omega-3 index and anti-arrhythmic potential of omega-3 PUFAs
    40. Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ
    41. The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions
    42. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE 2 induced ERK-1 and -2 and HIF-1α induction pathway
    43. Fish oil LC-PUFAs do not affect blood coagulation parameters and bleeding manifestations: Analysis of 8 clinical studies with selected patient groups on …
    44. Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation
    45. Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation
    46. The autonomic nervous system and cardiovascular disease: role of n-3 PUFAs
    47. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
    48. Microalgae n-3 PUFAs Production and Use in Food and Feed Industries
    49. Ratio of n-3/n-6 PUFAs and risk of breast cancer: a meta-analysis of 274135 adult females from 11 independent prospective studies
    50. Enhanced physicochemical stability of ω-3 PUFAs concentrates-loaded nanoliposomes decorated by chitosan/gelatin blend coatings
    51. N-3 PUFAs have antiproliferative and apoptotic effects on human colorectal cancer stem-like cells in vitro
    52. ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases
    53. Dietary polyunsaturated fatty acids (PUFAs): Uses and potential health benefits
    54. Delivery and turnover of plasma-derived essential PUFAs in mammalian brain
    55. N-3 PUFAs induce inflammatory tolerance by formation of KEAP1-containing SQSTM1/p62-bodies and activation of NFE2L2
    56. Elevation of n-3/n-6 PUFAs ratio suppresses mTORC1 and prevents colorectal carcinogenesis associated with APC mutation
    57. Effects of ω-3 PUFAs supplementation on myocardial function and oxidative stress markers in typical Rett syndrome
    58. Tropical marine macroalgae as potential sources of nutritionally important PUFAs
    59. Characterisation of the vasodilation effects of DHA and EPA, n-3 PUFAs (fish oils), in rat aorta and mesenteric resistance arteries
    60. Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders
    61. Roles of endogenous ether lipids and associated PUFAs in the regulation of ion channels and their relevance for disease
    62. Current evidence and future perspectives on n− 3 PUFAs
    63. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins—the Jerusalem Nutrition Study: high MUFAs vs high PUFAs
    64. Manipulation of omega‐3 PUFAs in lamb: Phenotypic and genotypic views
    65. What is the impact of n-3 PUFAs on inflammation markers in type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized …
    66. ω‐3 PUFAs Alleviate High‐Fat Diet–Induced Circadian Intestinal Microbes Dysbiosis
    67. Dietary intake of n-3 PUFAs modifies the absorption, distribution and bioavailability of fatty acids in the mouse gastrointestinal tract
    68. Omega-3 PUFAs and vitamin D co-supplementation as a safe-effective therapeutic approach for core symptoms of autism spectrum disorder: case report and literature …
    69. Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane
    70. Cardioprotective effects of ω-3 PUFAs in chronic kidney disease
    71. Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to …
    72. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells
    73. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress
    74. N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway
    75. Effect of omega-3 PUFAs supplementation with lifestyle modification on anthropometric indices and Vo2 max in overweight women
    76. n–3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral …
    77. n-3 PUFAs and cardiovascular disease prevention
    78. Cellular production of n-3 PUFAs and reduction of n-6–to–n-3 ratios in the pancreatic β-cells and islets enhance insulin secretion and confer protection against …
    79. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation
    80. Minerals, PUFAs and antioxidant properties of some tropical seaweeds from Saurashtra coast of India
    81. Marine n-3 PUFAs modulate IKs gating, channel expression, and location in membrane microdomains
    82. Lowering the n-6/n-3 PUFAs ratio inhibits the formation of THP-1 macrophage-derived foam cell
    83. Omega-3 PUFAs induce apoptosis of gastric cancer cells via ADORA1
    84. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype
    85. Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial
    86. PPARγ mediates a direct antiangiogenic effect of ω3-PUFAs in proliferative retinopathy
    87. Efficacy of polyunsaturated fatty acids (PUFAs) on impulsive behaviours and aggressiveness in psychiatric disorders
    88. Effect of low doses of long-chain n− 3 PUFAs on endothelial function and arterial stiffness: a randomized controlled trial
    89. Plant‐ and Fish‐Derived n‐3 PUFAs Suppress Citrobacter Rodentium–Induced Colonic Inflammation
    90. Metabolic syndrome: effects of n‐3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity
    91. ELOVL4 protein preferentially elongates 20: 5n3 to very long chain PUFAs over 20: 4n6 and 22: 6n3
    92. Enriching diet with n-3 PUFAs to help prevent cardiovascular diseases in healthy adults: Results from clinical trials
    93. n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse model
    94. n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity [S]
    95. The anticancer effects of Vitamin D and omega-3 PUFAs in combination via cod-liver oil: one plus one may equal more than two
    96. Treatment of LS174T colorectal cancer stem-like cells with n-3 PUFAs induces growth suppression through inhibition of survivin expression and induction of caspase …
    97. Recent evidence on the role of dietary PUFAs in cancer development and prevention
    98. Neurite outgrowth stimulation by n-3 and n-6 PUFAs of phospholipids in apoE-containing lipoproteins secreted from glial cells
    99. Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs
    100. Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction
    101. Drosophila lacks C20 and C22 PUFAs
    102. Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild …
    103. Nutritional and sensory properties of dry fermented sausages enriched with n− 3 PUFAs
    104. Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo
    105. N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity
    106. Fish as source of n-3 polyunsaturated fatty acids (PUFAs), which one is better-farmed or wild
    107. Omega-3 polyunsaturated fatty acids (n-3 PUFAs) in cardiovascular diseases (CVDs) and depression: the missing link?
    108. N-3 PUFAs Protect against Aortic Inflammation and Oxidative Stress in Angiotensin II-Infused Apolipoprotein E-/- Mice
    109. N-3 PUFAs inhibited hepatic ER stress induced by feeding of a high-saturated fat diet accompanied by the expression LOX-1
    110. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type …
    111. Novel anti-inflammatory ω-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus
    112. n-3 PUFAs inhibit TGFβ1-induced profibrogenic gene expression by ameliorating the repression of PPARγ in hepatic stellate cells
    113. EPA: DHA 6: 1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery …
    114. Relationship between the effect of polyunsaturated fatty acids (PUFAs) on brain plasticity and the improvement on cognition and behavior in individuals with autism …
    115. The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy
    116. Effects of n‐3 PUFAs on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance
    117. The effect of n-3 PUFAs on circulating adiponectin and leptin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled …
    118. Reduction of n-3 PUFAs, specifically DHA and EPA, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart
    119. Higher plasma phospholipid n–3 PUFAs, but lower n–6 PUFAs, are associated with lower pulse wave velocity among older adults
    120. Reconstitution of EPA and DHA biosynthesis in Arabidopsis: Iterative metabolic engineering for the synthesis of n− 3 LC-PUFAs in transgenic plants
    121. Combined buckwheat d-fagomine and fish omega-3 PUFAs stabilize the populations of gut Prevotella and Bacteroides while reducing weight gain in rats
    122. Dietary PUFAs attenuate NLRP3 inflammasome activation via enhancing macrophage autophagy
    123. The role of polyunsaturated fatty acids (n-3 PUFAs) on the pancreatic β-cells and insulin action
    124. N− 3 PUFAs modulate global gene expression profile in cultured rat cardiomyocytes. Implications in cardiac hypertrophy and heart failure
    125. Maternal dietary PUFAs intake and human milk content relationships during the first month of lactation
    126. Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C [S]
    127. n–3 PUFAs Reduce T-Helper 17 Cell Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Mouse Splenic CD4+ T Cells
    128. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A …
    129. Diversity of fatty acid composition of symbiotic dinoflagellates in corals: evidence for the transfer of host PUFAs to the symbionts
    130. Comparison of diatoms and dinoflagellates from different habitats as sources of PUFAs
    131. Alternative lipids to usual ω6 PUFAs: γ‐Linolenic acid, α‐linolenic acid, stearidonic acid, EPA, etc
    132. Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD)
    133. Analysis of Δ12-fatty acid desaturase function revealed that two distinct pathways are active for the synthesis of PUFAs in T. aureum ATCC 34304
    134. Lowered ω-3 PUFAs are related to major depression, but not to somatization syndrome
    135. Dietary intake of PUFAs and colorectal polyp risk
    136. Impulsivity-based thrifty eating phenotype and the protective role of n-3 PUFAs intake in adolescents
    137. Differential composition of DHA and very-long-chain PUFAs in rod and cone photoreceptors
    138. n− 3 PUFAs in cardiovascular disease
    139. Alterations in the intestinal assimilation of oxidized PUFAs are ameliorated by a polyphenol-rich grape seed extract in an in vitro model and Caco-2 cells
    140. Role of omega-3 PUFAs in neurobiological health
    141. Development of an LC-ESI (-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3-and n6-PUFAs
    142. Transgenic n-3 PUFAs enrichment leads to weight loss via modulating neuropeptides in hypothalamus
    143. Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects
    144. Role of oxylipins generated from dietary PUFAs in the modulation of endothelial cell function
    145. Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice
    146. Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system
    147. Polyunsaturated fatty acids (n-3 PUFAs) and inflammatory bowel disease (IBD): pathogenesis and treatment
    148. Maternal dietary intake of fish and PUFAs and child neurodevelopment at 6 months and 1 year of age: a nationwide birth cohort—the Japan Environment and …
    149. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with …
    150. Cytokine dysregulation in MECP2-and CDKL5-related Rett syndrome: relationships with aberrant redox homeostasis, inflammation, and ω-3 PUFAs
    151. Plasma phospholipid PUFAs are associated with greater muscle and knee extension strength but not with changes in muscle parameters in older adults
    152. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in≥ 75 years old patients: A randomized multicenter …
    153. Higher intake of PUFAs is associated with lower total and visceral adiposity and higher lean mass in a racially diverse sample of children
    154. Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport
    155. A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder
    156. A potential role of PUFAs and COXIBs in cancer chemoprevention
    157. Endogenous n-3 PUFAs attenuated olfactory bulbectomy-induced behavioral and metabolomic abnormalities in Fat-1 mice
    158. Biological activities of non-enzymatic oxygenated metabolites of polyunsaturated fatty acids (NEO-PUFAs) derived from EPA and DHA: New anti-arrhythmic …
    159. Pseudomonas aeruginosa responds to exogenous polyunsaturated fatty acids (PUFAs) by modifying phospholipid composition, membrane permeability, and …
    160. Formulation of mayonnaises containing PUFAs by the addition of microencapsulated chia seeds, pumpkin seeds and baru oils
    161. Fish-Oil–Derived n–3 PUFAs Reduce Inflammatory and Chemotactic Adipokine-Mediated Cross-talk between Co-cultured Murine Splenic CD8+ T Cells and …
    162. The Role of Nutraceuticals in Osteoarthritis Prevention and Treatment: Focus on n-3 PUFAs
    163. Anti-diabetic activity of PUFAs-rich extracts of Chlorella pyrenoidosa and Spirulina platensis in rats
    164. The anti-arrhythmic effects of n− 3 PUFAs
    165. Dietary n-3 PUFAs improve fresh and post-thaw semen quality in Holstein bulls via alteration of sperm fatty acid composition
    166. Myogenic differentiation and lipid-raft composition of L6 skeletal muscle cells are modulated by PUFAs
    167. The n-3 long-chain PUFAs modulate the impact of the GCKR Pro446Leu polymorphism on triglycerides in adolescents [S]
    168. Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes
    169. Re-assessing the mechanism of action of n− 3 PUFAs
    170. Red blood cell PUFAs reflect the phospholipid PUFA composition of major organs
    171. Supercritical fluid extraction from microalgae with high content of LC-PUFAs. A case of study: Sc-CO2 oil extraction from Schizochytrium sp
    172. … ω-3 polyunsaturated Fatty Acids (PUFAs) in an animal feeding study?—Effects of the temperature, oxygen level, and antioxidant on oxidative stability of ω-3 PUFAs in …
    173. Dietary long-chain n-3 PUFAs mitigate CD4+ T cell/adipocyte inflammatory interactions in co-culture models of obese adipose tissue
    174. n3 PUFAs Reduce Mouse CD4+ T-Cell Ex Vivo Polarization into Th17 Cells
    175. Prevention of cardiovascular diseases and highly concentrated n-3 polyunsaturated fatty acids (PUFAs)
    176. Macrophage fatty acid metabolism and atherosclerosis: the rise of PUFAs
    177. Impact of environment conditions on physicochemical characteristics of ovalbumin heat-induced nanoparticles and on their ability to bind PUFAs
    178. The regulation of leptin, leptin receptor and pro-opiomelanocortin expression by N-3 PUFAs in diet-induced obese mice is not related to the methylation of …
    179. Clinical trials of PUFAs in depression: State of the art
    180. Effects of Different n6/n3 PUFAs Dietary Ratio on Cardiac Diabetic Neuropathy
    181. In-depth study of the interaction, sensitivity, and gating modulation by PUFAs on K+ channels; interaction and new targets
    182. Habitual consumption of long-chain n–3 PUFAs and fish attenuates genetically associated long-term weight gain
    183. “Force-from-lipids” gating of mechanosensitive channels modulated by PUFAs
    184. Reduced protein oxidation in Wistar rats supplemented with marine ω3 PUFAs
    185. Does diet matter? The use of polyunsaturated fatty acids (PUFAs) and other dietary supplements in inflammation-associated depression
    186. Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype
    187. Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement
    188. Influence of genetic variants in FADS2 and ELOVL2 genes on BMI and PUFAs homeostasis in children and adolescents with obesity
    189. Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion
    190. Dietary fish hydrolysate supplementation containing n-3 LC-PUFAs and peptides prevents short-term memory and stress response deficits in aged mice
    191. n-3 PUFAs protect against adiposity and fatty liver by promoting browning in postnatally overfed male rats: a role for NRG4
    192. Protective actions of soy isoflavones and n-3 PUFAs on bone mass in ovariectomized rats
    193. Agonistic effect of polyunsaturated fatty acids (PUFAs) and its metabolites on brain-derived neurotrophic factor (BDNF) through molecular docking simulation
    194. n3 PUFAs do not affect adipose tissue inflammation in overweight to moderately obese men and women
    195. Saturated fatty acids, MUFAs and PUFAs regulate ferroptosis
    196. The effects of vitamin E and omega-3 PUFAs on endothelial function among adolescents with metabolic syndrome
    197. Nutrient biomarkers shape individual differences in functional brain connectivity: Evidence from omega‐3 PUFAs
    198. Capsaicin analogues derived from n-3 polyunsaturated fatty acids (PUFAs) reduce inflammatory activity of macrophages and stimulate insulin secretion by β-cells in …
    199. PUFAs acutely affect triacylglycerol-derived skeletal muscle fatty acid uptake and increase postprandial insulin sensitivity
    200. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial
    201. PPARα-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasis
    202. Motivational factors for consuming omega-3 PUFAs: An exploratory study with Danish consumers
    203. Development of a food-exchange model to replace saturated fat with MUFAs and n–6 PUFAs in adults at moderate cardiovascular risk
    204. Krill oil treatment increases distinct PUFAs and oxylipins in adipose tissue and liver and attenuates obesity-associated inflammation via direct and indirect mechanisms
    205. The marine halophytes Carpobrotus edulis L. and Arthrocnemum macrostachyum L. are potential sources of nutritionally important PUFAs and metabolites with …
    206. Biosynthesis of LC-PUFAs and VLC-PUFAs in Pampus argenteus: Characterization of Elovl4 Elongases and Regulation under Acute Salinity
    207. The role of vitamin D and omega-3 PUFAs in islet transplantation
    208. Effects of combined d-fagomine and omega-3 PUFAs on gut microbiota subpopulations and diabetes risk factors in rats fed a high-fat diet
    209. Protective effect of ω-3 polyunsaturated fatty acids (PUFAs) on sodium nitroprusside–induced nephrotoxicity and oxidative damage in rat kidney
    210. Dietary LA and sex effects on oxylipin profiles in rat kidney, liver, and serum differ from their effects on PUFAs
    211. Association between fish and shellfish, and omega-3 PUFAs intake and CVD risk factors in middle-aged female patients with type 2 diabetes
    212. Polyunsaturated Fatty Acids (PUFAs) Content of the Fungus Mortierella alpina Isolated from Soil
    213. Hepatoprotective effect of Omega-3 PUFAs against acute paracetamol-induced hepatic injury confirmed by FTIR
    214. Intakes of PUFAs were inversely associated with plasma C-reactive protein 12 years later in a middle-aged population with vitamin E intake as an effect modifier
    215. … acid composition on growth, fatty acids composition and hepatic lipid metabolism in juvenile turbot (Scophthalmus maximus L.) fed diets with required n3 LC-PUFAs
    216. Dietary Echium Oil Increases Long-Chain n–3 PUFAs, Including Docosapentaenoic Acid, in Blood Fractions and Alters Biochemical Markers for Cardiovascular …
    217. Role of PUFAs, the precursors of endocannabinoids, in human obesity and type 2 diabetes
    218. All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts
    219. The effects of plant growth regulators on cell growth, protein, carotenoid, PUFAs and lipid production of Chlorella pyrenoidosa ZF strain
    220. Lipase-catalyzed methanolysis of microalgae oil for biodiesel production and PUFAs concentration
    221. Dietary cholesterol increases the risk whereas PUFAs reduce the risk of active tuberculosis in Singapore Chinese
    222. PUFAs supplementation affects the renal expression of pannexin 1 and connexins in diabetic kidney of rats
    223. Polyunsaturated fatty acids (PUFAs) levels in patients with cardiovascular diseases (CVDs) with and without depression
    224. In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice
    225. Detection of conjugated C16 PUFAs in rat tissues as possible partial beta-oxidation products of naturally occurring conjugated linoleic acid and its metabolites
    226. Enzymatic ethanolysis of fish oil for selective concentration of polyunsaturated fatty acids (PUFAs) with flexible production of corresponding glycerides and ethyl esters
    227. Comparative analysis reveals unexpected genome features of newly isolated Thraustochytrids strains: on ecological function and PUFAs biosynthesis
    228. Milk Fatty Acid Profiles in Different Animal Species: Focus on the Potential Effect of Selected PUFAs on Metabolism and Brain Functions
    229. Endogenous n-3 polyunsaturated fatty acids (PUFAs) mitigate ovariectomy-induced bone loss by attenuating bone marrow adipogenesis in FAT1 transgenic …
    230. n–3 long-chain PUFAs reduce respiratory morbidity caused by iron supplementation in iron-deficient South African schoolchildren: a randomized, double-blind …
    231. Metabolic shift induced by ω-3 PUFAs and rapamycin lead to cancer cell death
    232. ω-3 PUFAs and resveratrol differently modulate acute and chronic inflammatory processes
    233. Short-term consumption of n-3 PUFAs increases murine IL-5 levels, but IL-5 is not the mechanistic link between n-3 fatty acids and changes in B-cell populations
    234. Asymmetric binding and metabolism of polyunsaturated fatty acids (PUFAs) by CYP2J2 epoxygenase
    235. Insight into the contribution of isoprostanoids to the health effects of omega 3 PUFAs
    236. GPR120 is not required for ω‐3 PUFAs‐induced cell growth inhibition and apoptosis in breast cancer cells
    237. Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified α-linolenic acid in unanesthetized rats
    238. Functions of enyolreductase (ER) domains of PKS cluster in lipid synthesis and enhancement of PUFAs accumulation in Schizochytrium limacinum SR21 using …
    239. Modulation of the mRNA of the Nlrp3 inflammasome by Morin and PUFAs in an obesity model induced by a high-fat diet
    240. … enzymatic synthesis, characterization, in vitro antioxidant capacity and oxidative stability studies of novel phosphatidylcholines with ω-3/ω-6 PUFAs and phenolic acids
    241. Effects of nitrogen and phosphorous stress on the formation of high value LC-PUFAs in Porphyridium cruentum
    242. Aging and FADS1 polymorphisms decrease the biosynthetic capacity of long-chain PUFAs: A human trial using [U-13C] linoleic acid
    243. Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs
    244. Overconsumption of Omega-6 Polyunsaturated Fatty Acids (PUFAs) versus Deficiency of Omega-3 PUFAs in Modern-Day Diets: The Disturbing Factor for …
    245. Dietary supplementation with olive oil leads to improved lipoprotein spectrum and lower n-6 PUFAs in elderly subjects
    246. Effects of the combination of ω-3 PUFAs and proanthocyanidins on the gut microbiota of healthy rats
    247. Dietary intake and sources of long-chain n-3 PUFAs in German adults
    248. Changes in liver proteins of rats fed standard and high-fat and sucrose diets induced by fish omega-3 PUFAs and their combination with grape polyphenols according …
    249. PUFAs and PUAs production in three benthic diatoms from the northern Adriatic Sea
    250. Synergistic anti-tumor effects of melatonin and PUFAs from walnuts in a murine mammary adenocarcinoma model
    251. PUFAs, BDNF and lipoxin A4 inhibit chemical-induced cytotoxicity of RIN5F cells in vitro and streptozotocin-induced type 2 diabetes mellitus in vivo
    252. Effects of n-3 polyunsaturated fatty acids (PUFAs) on circulating adiponectin and leptin in subjects with type 2 diabetes mellitus
    253. Omega-3 PUFAs Suppress IL-1β-Induced Hyperactivity of Immunoproteasomes in Astrocytes
    254. Targeting neuroinflammation: The therapeutic potential of ω-3 PUFAs in substance abuse
    255. Metabolic Engineering Strategies for the Enhanced Microalgal Production of Long‐Chain Polyunsaturated Fatty Acids (LC‐PUFAs)
    256. Human milk plasmalogens are highly enriched in long-chain PUFAs
    257. Influences of polyunsaturated fatty acids (PUFAs) on growth and secondary metabolite accumulation in Panax ginseng CA Meyer adventitious roots cultured …
    258. Modulation of the liver protein carbonylome by the combined effect of marine omega-3 PUFAs and grape polyphenols supplementation in rats fed an obesogenic high …
    259. Increased FADS2-derived n-6 PUFAs and reduced n-3 PUFAs in plasma of atopic dermatitis patients
    260. Exogenous polyunsaturated fatty acids (PUFAs) alter phospholipid composition, membrane permeability, biofilm formation and motility in Acinetobacter baumannii
    261. Effect of feeding barbel larvae (Barbus barbus (L, 1758)) Artemia sp. nauplii enriched with PUFAs on their growth and survival rate, blood composition …
    262. Effects of concentrates with different contents of protected fat rich in PUFAs on the performance lactating Granadina goats: Part II. Milk production and composition
    263. Association of serum phospholipid PUFAs with cardiometabolic risk: beneficial effect of DHA on the suppression of vascular proliferation/inflammation
    264. Therapeutic management of canine atopic dermatitis by combination of pentoxifylline and PUFAs
    265. PUFAs enhance oxidative stress and apoptosis in tumour cells exposed to hypericin-mediated PDT
    266. Regulation mechanism of silkworm pupa oil PUFAs on cholesterol metabolism in hepatic cell L‐02
    267. Quality evaluation of Oviductus Ranae based on PUFAs using HPLC fingerprint techniques combined with chemometric methods
    268. Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute …
    269. Effect of dietary n− 3 LC-PUFAs on plasma vitellogenin, sex steroids, and ovarian steroidogenesis during vitellogenesis in female silver pomfret (Pampus argenteus) …
    270. Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death
    271. Transcriptomic Profiling and Gene Disruption Revealed that Two Genes Related to PUFAs/DHA Biosynthesis May be Essential for Cell Growth of Aurantiochytrium sp.
    272. ω3-PUFAs exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients
    273. Significant enrichment of polyunsaturated fatty acids (PUFAs) in the lipids extracted by supercritical CO2 from the livers of Australian rock lobsters (Jasus edwardsii)
    274. Use of n-3 PUFAs can decrease the mortality in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis
    275. Association of n-6 PUFAs with the risk of diabetic retinopathy in diabetic patients
    276. PUFAs in serum cholesterol ester and oxidative DNA damage in Japanese men and women
    277. Elovl4 and Fa2h expression during rat spermatogenesis: a link to the very-long-chain PUFAs typical of germ cell sphingolipids [S]
    278. A combination of Omega-3 PUFAs and COX inhibitors: a novel strategy to manage obesity-linked dyslipidemia and adipose tissue inflammation
    279. Induction of apoptosis and lipogenesis in human preadipocyte cell line by n −3 PUFAs
    280. Metabolomic approach to the nutraceutical effect of rosemary extract plus Ω-3 PUFAs in diabetic children with capillary electrophoresis
    281. UV effects on stoichiometry and PUFAs of Selenastrum capricornutum and their consequences for the grazer Daphnia magna
    282. Erythrocyte PUFAs, circulating acylcarnitines, and metabolic syndrome risk: a prospective study in Chinese [S]
    283. Maternal pre-pregnancy weight status modifies the influence of PUFAs and inflammatory biomarkers in breastmilk on infant growth
    284. Atypical surface behavior of ceramides with nonhydroxy and 2-hydroxy very long-chain (C28–C32) PUFAs
    285. Effect of polyunsaturated fatty acids (PUFAs) on airway epithelial cells’ tight junction
    286. The impact of PLA2G4A and PTGS2 gene polymorphisms, and red blood cell PUFAs deficit on niacin skin flush response in schizophrenia patients
    287. Correction: N-3 Polyunsaturated Fatty Acids (PUFAs) reverse the impact of early-life stress on the gut microbiota
    288. n− 3 PUFAs—From dietary supplements to medicines
    289. Beneficial effects of an endogenous enrichment in n3‐PUFAs on Wnt signaling are associated with attenuation of alcohol‐mediated liver disease in mice
    290. Production of C20 polyunsaturated fatty acids (PUFAs) by pathway engineering: identification of a PUFA elongase component from Caenorhabditis elegans
    291. Production of gymnemic acid from hairy root cultures of Gymnema sylvestre R. Br. as influenced by polyunsaturated fatty acids (PUFAs) and their antioxidant activity
    292. n-3 PUFAs improve erythrocyte fatty acid profile in patients with small AAA: a randomized controlled trial
    293. A novel clean process for the combined production of fatty acid ethyl esters (FAEEs) and the ethyl ester of polyunsaturated fatty acids (PUFAs) from microalgae oils
    294. Linoleic acid intake and reduction in mortality: the icing on the cake of health benefits from n–6 PUFAs?
    295. Higher erythrocyte n–3 PUFAs are associated with decreased blood pressure in middle-aged and elderly chinese adults
    296. Regulatory Effects of N-3 PUFAs on Pancreatic β-cells and Insulin-sensitive Tissues
    297. Supplementation of polyunsaturated fatty acids (PUFAs) and aerobic exercise improve functioning, morphology, and redox balance in prostate obese rats
    298. The status of ω-3 PUFAs influence chronic unpredicted mild stress-induced metabolic side effects in rats through INSIG/SREBP pathway
    299. Plasma glycerophospholipid profile, erythrocyte n–3 PUFAs, and metabolic syndrome incidence: a prospective study in Chinese men and women
    300. Long-chain n-3 PUFAs from fish oil enhance resting state brain glucose utilization and reduce anxiety in an adult nonhuman primate, the grey mouse lemur
    301. Effects of concentrates with different contents of protected fat rich in PUFAs on the performance of lactating Granadina goats: 1. Feed intake, nutrient digestibility, N …
    302. The effect of oral administration of PUFAs on the matrix metalloproteinase expression in gastric adenocarcinoma patients undergoing chemotherapy
    303. Effects of dietary n‐3 long‐chain polyunsaturated fatty acids (n‐3 LC‐PUFAs) on growth performance, body composition and subcutaneous adipose tissue …
    304. Effects of PUFAs on animal reproduction: male and female performances and endocrine mechanisms
    305. Diets enriched in PUFAs at an early postimplantation stage prevent embryo resorptions and impaired mTOR signaling in the decidua from diabetic rats
    306. Association of PLA2G4A with myocardial infarction is modulated by dietary PUFAs
    307. Combined urea complexation and argentated silica gel column chromatography for concentration and separation of PUFAs from tuna oil: based on improved DPA …
    308. Production of transgenic beef cattle rich in n-3 PUFAs by somatic cell nuclear transfer
    309. Quality changes of N-3 PUFAs enriched and conventional eggs under different home storage conditions with wireless sensor network
    310. ω-3 PUFAs, breast and prostate cancer: experimental studies
    311. Iodine, PUFAs and Iodolipids in Health and Diseases: An Evolutionary Perspective.
    312. n-3 PUFAs and heart failure
    313. Formation of conjugated diene and triene products in lipoxygenase oxidation of C18, C20, C22 PUFAs
    314. DHA-rich n-3 PUFAs intake from the early-and mid-pregnancy decreases the weight gain by affecting the DNA methylation status among Chinese Han infants
    315. Perspectives on n-3 PUFAs: primary prevention, antiarrhythmic effects, congestive heart failure
    316. Poor infant inhibitory control predicts food fussiness in childhood–a possible protective role of n-3 PUFAs for vulnerable children
    317. Effect of Milk-Based Infant Formula Fortified with PUFAs on Lipid Profile, Growth and Micronutrient Status of Young Children: A Randomized Double-Blind Clinical …
    318. Plastidic Δ6 Fatty-Acid Desaturases with Distinctive Substrate Specificity Regulate the Pool of C18-PUFAs in the Ancestral Picoalga Ostreococcus tauri
    319. Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy
    320. n-6 PUFAs downregulate expression of the tricarboxylate carrier in rat liver by transcriptional and posttranscriptional mechanisms
    321. … fatty acids (PUFAs) between animal studies and clinical meta-analyses: a review with several strategies to enhance the beneficial effects of n-3 PUFAs
    322. Investigation of the physiological properties and synthesis of PUFAs from thraustochytrids and its electrophoretic karyotypes
    323. n-3 PUFAs: an elixir in prevention of colorectal cancer
    324. Supplementation with a powdered blend of PUFAs normalizes DHA and AA levels in patients with PKU
    325. Ileum Gene Expression in Response to Acute Systemic Inflammation in Mice Chronically Fed Ethanol: Beneficial Effects of Elevated Tissue n-3 PUFAs
    326. Effects of polyunsaturated fatty acids (PUFAs) on gonadal maturation and spawning of striped gourami, Colisa fasciatus
    327. Unique thermal behavior of sphingomyelin species with nonhydroxy and 2-hydroxy very-long-chain (C28-C32) PUFAs
    328. … factors for two-stage cultivation of newly isolated oleaginous microalgae from local lake as promising sources of pigments, PUFAs and biodiesel feedstocks
    329. … (SFAs) as present in foods or diets with mixtures of monounsaturated fatty acids (MUFAs) and/or mixtures of polyunsaturated fatty acids (PUFAs), and maintenance of …
    330. Associations between long-chain PUFAs in maternal blood, cord blood, and breast milk and offspring body composition up to 5 years: follow-up from the INFAT study
    331. PCSK9 variant, long-chain n–3 PUFAs, and risk of nonfatal myocardial infarction in Costa Rican Hispanics
    332. Composition of long chain polyunsaturated fatty acids (LC-PUFAs) in different encephalic regions and its association with behavior in spontaneous hypertensive rat …
    333. Assessment of Arabian Gulf Seaweeds from Kuwait as Sources of Nutritionally Important Polyunsaturated Fatty Acids (PUFAs)
    334. Plasma and Red Blood Cell PUFAs in Home Parenteral Nutrition Paediatric Patients—Effects of Lipid Emulsions
    335. Omega‐3 PUFAs and Atrial Fibrillation: Have We Made Up Our Mind Yet?
    336. Quantification of the major ω-3, ω-6 PUFAs using the Purdie assay and their ratios in different cholesterol types and the effects of gender and cholesterol on PUFA …
    337. Health benefits of polyunsaturated fatty acids (PUFAs)
    338. trans Isomeric fatty acids are inversely related to the availability of long-chain PUFAs in the perinatal period
    339. Allylic hydrogen abstraction II. H-abstraction from 1, 4 type polyalkenes as a model for free radical trapping by polyunsaturated fatty acids (PUFAs)
    340. Dietary intake and adipose tissue content of long-chain n–3 PUFAs and subsequent 5-y change in body weight and waist circumference
    341. Elaidic, vaccenic, and rumenic acid status during pregnancy: association with maternal plasmatic LC-PUFAs and atopic manifestations in infants
    342. Regulation of cholesterol metabolism in liver: link to NAFLD and impact of n-3 PUFAs
    343. Granulation Tissue Enhanced with Aspirin and Omega‐3 PUFAs as a Local Adjunct to the Surgical Treatment of Periodontitis
    344. Luminal Bioavailability of Orally Administered ω-3 PUFAs in the Distal Small Intestine, and Associated Changes to the Ileal Microbiome, in Humans with a Temporary …
    345. Effect of PUFAs oral administration on the amount of apoptotic caspases enzymes in gastric cancer patients undergoing chemotherapy
    346. Enrichment of omega‐3 PUFAs from fur seal oil
    347. C19 odd-chain polyunsaturated fatty acids (PUFAs) are metabolized to C21-PUFAs in a rat liver cell line, and curcumin, gallic acid, and their related compounds inhibit …
    348. Identification and characterization of a novel enzyme related to the synthesis of PUFAs derived from Thraustochytrium aureum ATCC 34304
    349. P4: PEMT, PCs, PUFAs, and prematurity
    350. Effect of pretreatment with omega-3 polyunsaturated fatty acids (PUFAs) on hematological parameters and platelets aggregation in patients during elective coronary …
    351. A third-generation lipid emulsion that contains n–3 long-chain PUFAs preserves retinal function in parenterally fed neonatal piglets
    352. Efficiency of PUFAs incorporation from marine sources in yolk egg’s laying hens
    353. Maternal n-3 PUFAs deficiency during pregnancy inhibits neural progenitor cell proliferation in fetal rat cerebral cortex
    354. Potential toxicity of microalgal polyunsaturated fatty acids (PUFAs).
    355. PC60 SPANISH PREGNANT WOMEN’S PLASMA PHOSPHOLIPIDS LC-PUFAs CONCENTRATIONS & ITS INFLUENCE ON THEIR NEWBORNS
    356. Transgenic pigs carrying a synthesized fatty acid desaturase gene yield high level of co-3 PUFAs
    357. Amyotrophic Lateral Sclerosis Risk, Family Income, and Fish Consumption Estimates of Mercury and Omega-3 PUFAs in the United States
    358. Plant n-3 PUFA intake may lower the risk of atherosclerotic cardiovascular disease only among subjects with a low intake of marine n-3 PUFAs
    359. Are There Benefits to Growth with Supplementing Long-Chain PUFAs to Toddlers Born Prematurely?
    360. ω-3 PUFAs and prostate cancer: epidemiological studies
    361. Dietary marine n–3 PUFAs do not affect stress-induced visceral hypersensitivity in a rat maternal separation model
    362. Effect of parenteral lipid emulsion on preterm infant PUFAs and their downstream metabolites
    363. Influence of omega-3 PUFAs on the metabolism of proanthocyanidins in rats
    364. Lipoic Acid Prevents Suppression of Connective Tissue Proliferation in the Rat Liver Induced by n–3 PUFAs
    365. Using polyunsaturated fatty acids (PUFAs) as functional ingredients
    366. Thermal behavior of liposomes containing PCs with long and very long chain PUFAs isolated from retinal rod outer segment membranes
    367. Preparation of n-3 PUFAs ethyl esters by an efficient biocatalyzed solvent-free process
    368. Effect of marine vegetal sources on the hen diets on the PUFAs and PUFAs n-3 in laying hens egg yolk and plasm
    369. Favorable effects of omega-3 PUFAs on glucose control in an adolescent with type 1 diabetes using continuous glucose monitoring: a case report
    370. Content of polyunsaturated fatty acids (PUFAs) in serum and liver of rats fed restricted diets supplemented with vitamins B2, B6 and folic acid
    371. Identification of genes selectively regulated in human hepatoma cells by treatment with dyslipidemic sera and PUFAs
    372. Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for …
    373. Development of meat and poultry products enriched with n-3 PUFAs and their functional role
    374. Novel “Matrix-Corrected Calibration” study for the detection of polyunsaturated fatty acids (PUFAs) in plasma and erythrocytes by means of a gas chromatography …
    375. Effects of supplementation of the Tris-egg yolk extender with n-3 polyunsaturated fatty acids (PUFAs) on frozen-thawed ram semen characteristics
    376. Effects of dietary long chain PUFAs on hippocampal lipid peroxidation and NMDA receptor subunits A and B concentration in streptozotocin-diabetic rats
    377. The role of serum monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) in cardiovascular disease risk
    378. Effects of dietary omega-3 PUFAs on growth and development: Somatic, neurobiological and reproductive functions in a murine model
    379. Direct esterification method for analysis of long-chain polyunsaturated fatty acids (LC-PUFAs) in infant formulae
    380. Egg yolk enriched with polyunsaturated fatty acids (PUFAs) improves the shelf life of ram semen in liquid storage
    381. Variability in the cardiometabolic effects of ω-3 long-chain PUFAs: background diet, timing, and genetics
    382. Effects of PUFAs in a mouse model of HSV-1 chorioretinitis
    383. Insights into the function of n-3 PUFAs in fat-1 transgenic cattle
    384. ω-3 PUFAs: Interventional Trials for the Prevention and Treatment of Breast and Prostate Cancer
    385. Effect of fodder enrichment with PUFAs on quail eggs
    386. Effects of baked and raw salmon fillet on lipids and n-3 PUFAs in serum and tissues in Zucker fa/fa rats​​​​​​​​​​​​​​​​​​​​
    387. Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter
    388. Two sides of the same coin: NEO‐PUFAs in Rett syndrome and post‐infarction cardiac arrhythmias
    389. Effects of n-3 PUFAs on intestinal mucosa innate immunity and intestinal microbiota in mice after hemorrhagic shock resuscitation
    390. Functional LC ω‐3 PUFAs in pregnancy: a short review of the literature
    391. Influence of dietary n‐3 polyunsaturated fatty acids (PUFAs) on growth, PUFA composition and the expression of FAD6 and ELOV5 in pacific white shrimp …
    392. ω-3 PUFAs and colon cancer: experimental studies and human interventional trials
    393. Combination of low dose major n3 PUFAs in fresh water mussel lipid is an alternative of EPA–DHA supplementation in inflammatory conditions of arthritis and LPS …
    394. Microalgae as a Source of Functional PUFAs: A Green Low-cost Pathway via Enzymatic Hydrolysis
    395. A weighty matter: can PUFAs in pregnancy prevent obesity?
    396. Modulation of plasma levels and percentages of incorporation of ω-3 PUFAs in egg yolk under the influence of supplementation sources rich in omega 3 to diet of …
    397. Abstract P1-03-12: The ratio of omega-3 to omega-6 PUFAs impact cancer cell phenotype in the tumor microenvironment
    398. Polyunsaturated fatty acids (PUFAs) OF MUCOR sp. with special reference to gamma linolenic acid (GLA)
    399. Effects of polyunsaturated fatty acids (PUFAs) in the treatment of experimental chronic renal failure
    400. Effect of PUFAs from Pteleopsis suberosa stem bark on androgenic enzymes, cellular ATP and prostatic acid phosphatase in mercury chloride–exposed rat
    401. Losses in n-3 PUFAs during oxidation of fish lipids
    402. Exogenous polyunsaturated fatty acids (PUFAs) promote changes in growth, phospholipid composition, membrane permeability and virulence phenotypes in …
    403. Rice bran in the diet as an enriching source of long chain Omega (n-3) poly unsaturated fatty acids (LC n-3 PUFAs) in fillets of genetically improved farmed …
    404. Oxidative stress and cancer: Role of n-3 PUFAs
    405. Effects of supplementation with fish oil and n-3 PUFAs enriched egg yolk phospholipids on anhedonic-like response and body weight in the rat chronic mild stress …
    406. Selective concentration of PUFAs in glyceride from fish oil with immobilized lipase
    407. The effect of PUFAs in silkworm pupa oil on serum lipids, EPA and DHA levels in rats
    408. The apoptosis-inducing effects of polyunsaturated fatty acids (PUFAs) on benign and malignant breast cells in vitro
    409. Effect of n-3 PUFAs on markers of inflammation in arthritic horses
    410. An Approach for Examining the Impact of Food Group-Based Sources of Nutrients on Outcomes with Application to PUFAs and LDL in Youth with Type 1 Diabetes
    411. The anxiolytic activity of n-3 PUFAs enriched egg yolk phospholipids in rat behavioral studies
    412. Progress in the role of ω-3 PUFAs in regulating the genesis and development of colorectal cancer
    413. Advances in the Production of PUFAs by the Culture of Mocroalgae [J]
    414. Simultaneous Enrichment of Eggs With PUFAs and Antioxidants
    415. ω-3 PUFAs and colon cancer: epidemiological studies
    416. ω-3 PUFAs in the prevention and cure of inflammatory, degenerative, and neoplastic diseases 2014
    417. Trophic Transfer of PUFAs—’Vital Ones Reach Top Predators’
    418. Anthracyclins increase free PUFAs and etherPEs with PUFAs as potential hallmarks of lipid peroxidation and ferroptosis
    419. Genome-Wide Interaction Study of Omega-3 PUFAs and Other Fatty Acids on Inflammatory Biomarkers of Cardiovascular Health in the Framingham Heart Study
    420. Are PUFAs n-3 really important in diet?
    421. New marine sources of polyunsaturated fatty acids (PUFAs)
    422. Alternative n-3 PUFAs Sources in Central European Diet before Westernization-Case Report from Poland
    423. LC-PUFAs in Reproduction and Behavior—’Good Cop–Bad Cop?’
    424. Influence of long-chain polyunsaturated fatty acids (LC-PUFAs) on cognitive and visual development
    425. Triacylglycerols Participate in the Eukaryotic Pathway of PUFAs Biosynthesis in the Red Microalga Porphyridium Cruentum
    426. ω-3 Polyunsaturated fatty acids (PUFAs or fish oils) and atrial fibrillation
    427. Digestive utilization of the fat and individual fatty acids of a protected fat rich in PUFAs in goats
    428. PUFAs and risk of cognitive decline or dementia: epidemiological data
    429. Omega-3 PUFAs and gut microbiota: A preventive approach for colorectal cancer
    430. Commentary to:“The use of high-dose omega-3 PUFAs and vitamin-d co-supplementation as a therapeutic approach for ibd-related symptoms: Case report and …
    431. PUFAs and IBD: is there a relationship?
    432. Dietary profile of n‐3 series LC‐PUFAs in rainbow trout under regular stripping condition: Semen production and quality, hepato‐somatic index, haemato …
    433. PUFAs in sickle cell disease
    434. GLA PURIFICATION FROM ECHIUM FASTUOSUM SEED OIL IN A TWO‐STEP PROCESS: SIMULTANEOUS PUFAs EXTRACTION/CONCENTRATION AND …
    435. ω-3 PUFAs, why are we speaking of them?
    436. The use of high-dose omega-3 PUFAs and vitamin-d co-supplementation as a therapeutic approach for ibd-related symptoms: Case report and literature review
    437. Correction: Efficacy of omega-3 PUFAs in depression: A meta-analysis
    438. Combating atherosclerosis with heavy PUFAs: Deuteron not proton is the first
    439. A Survey on the possibility of concurrent enrichment of broiler chicken meat with CLA and n-3 type PUFAs
    440. Investigation of the mechanisms underlying the vascular relaxation mediated by n-3 PUFAs (fish oils), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) …
    441. P2253 Intake of the omega 3 PUFAs formulation EPA: DHA 6: 1 by aged rats reduced shedding of microvesicles from spleen-derived cultured leukocytes and their …
    442. Producing polyunsaturated fatty acids (PUFAs) from plant sources
    443. N-3 PUFAs and neuroinflammatory processes in cognitive disorders
    444. Corrigendum to “A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of …
    445. Effect of PUFA-rich supplements from marine sources in the feed of laying hens on lipid composition and the percentage of incorporation of n-6 PUFAs in egg yolk.
    446. Omega-3 polyunsaturated fatty acids (PUFAs) as food ingredients
    447. MP63-01 PREVENTATIVE EFFECT OF OMEGA-3 POLYUNSATURATED FATTY ACIDS (N-3 PUFAs) AGAINST INDUCTION OF BLADDER CANCER (BC) IN A RAT …
    448. Omega-6 PUFAs and T2DM
    449. -3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases
    450. Inflammation, C-reactive protein and cardiometabolic risk: how compelling is the potential therapeutic role of n. 3 PUFAs in cardiovascular disease?
    451. n-3 polyunsaturated fatty acids (PUFAs) inhibit mast cell activation by disrupting FcϵRI association with lipid rafts (HYP3P. 401)
    452. Effect of growth media modifications on cell biomass and polyunsaturated fatty acids (PUFAs) production from Shewanella frigidimarina
    453. Caracterización de diversas especies de peces como fuente de PUFAs y omega 3 según su perfil de ácidos grasos
    454. … OF PRETERM FORMULAS (PTF) WITH A LOW-EPA FISH OIL: EFFECT ON POLYUNSATURATED FATTY ACIDS (PUFAs) STATUS AND GROWTH.
    455. Supplementing Mothers and their Offspring with Long-Chain ω–3 PUFAs Offers no Benefit Compared with Placebo in Infant Development
    456. NIR Spectroscopy: A Non-destructive method for PUFAs determination of forage from permanent grassland
    457. MON-129 Analysis of Omega3 PUFAs Status Among the Female and Male Population of the Moscow Region
    458. Research on Synthesis Technology of PUFAs Glyceride [J]
    459. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in [greater than or equal to] 75 years old patients: A randomized …
    460. Omega‐3 polyunsaturated fatty acids (n‐3 PUFAs) induce apoptosis in breast cancer cells through activation and translocation of neutral sphingomyelinase‐2 (N …
    461. Eect of 3 months dietary supplementation with omega-3 α-linolenic acid (ala) and polyunsaturated fatty acids (PUFAs)(Alphalife Freia Framaceutici Srl) …
    462. Dietary n-3 PUFAs augment caspase 8 activation in Staphylococcal aureus enterotoxin B stimulated T-cells
    463. STUDIES ON THE IN VITRO ANTITUMOR ACTIVITY OF PUFAs AND CORRESPONDING Se-PUFAs
    464. Transgenic n-3 PUFAs Enrichment Regulates Related Physiological Activities by Affecting Nerves
    465. A primary study on the extraction and enrichment of the PUFAs from algae
    466. Almonds and walnuts consumption modifies PUFAs profiles and improves metabolic inflammation beyond the impact on anthropometric measure
    467. Endogenous production of n-3 PUFAs protects mice from CCl4 -induced liver fibrosis by regulating mTOR and Bcl-2/Bax signaling pathways.
    468. Influence of Microalgae Dietary Administration on ω3 LC-PUFAs Meat Content of Muscovy Duck
    469. Influence of canola oil in broiler diets and its effects of MUFAs and PUFAs contents in selected tissues.
    470. Assessment of the effect of the increased content of vegetable oils rich in PUFAs on the fatty acid composition and quality of beef
    471. Beneficial potency of algae-based polyunsaturated fatty acids (PUFAs) for cancer therapy
    472. … Role in Extending Lifespan and Reproductive Capacity in White Leghorn Laying Hens; and the Effect of Polyunsaturated Fatty Acids (PUFAs) on Lipid Metabolism …
    473. Effect of n-3 polyunsaturated fatty acids (PUFAs) on lipid peroxidation, plasma homocysteine levels and antioxidant status in normolipidemic subjects
    474. Dietary supplementation with PUFAs rescues the eggshell defects caused by seipin mutations in C. elegans
    475. Therapeutic efficacy of a nutritional combination of n-3 PUFAs and Arctium Llappa extract on canine atopic dermatitis
    476. Farm-made feed for polyunsaturated fatty acids (PUFAs) rich carp production in India: a case study
    477. Effect of PUFAs on extracellular matrix production and remodeling in vascular smooth muscle cell cultures in an atherosclerotic model
    478. Using antioxidant to enhance liver cancer preventive effect of n-3 PUFAs
    479. Front Cover: ω‐3 PUFAs Alleviate High‐Fat Diet–Induced Circadian Intestinal Microbes Dysbiosis
    480. Determination of LC-PUFAs and Protein Content in Premature infant formula powders by ATR-FTIR Spectroscopy and Chemometrics
    481. Production of PUFAs as Dietary and Health Supplements from Oleaginous Microalgae Utilizing Inexpensive Renewable Substrates
    482. Serum Urate, PUFAs and Abdominal Obesity in Hispanic Children: The Viva La Familia Study
    483. Isolation and Evaluation of Anti-inflammatory activity of Epigallocatechin from Senegalia rugata along with PUFAs
    484. Plastidic Δ6 fatty-acid desaturases with distinctive substrate specificity regulate the pool of c18-PUFAs in the ancestral picoalga ostreococcus tauri
    485. Effects of Culture Medium on PUFAs Production by Mortierella isabellinas
    486. PUFAs and Their Metabolites in Carcinogenesis
    487. Kid goat deposits composition in response to maternal intake of a protected fat rich in PUFAs
    488. Additional data from our study on fatty acids variations during lactation: Correlations between n-3 and n-6 PUFAs in human colostrum, transitional, and mature milk
    489. Serum polyunsaturated fatty acid (PUFAs) levels as a risk factor for the post-operative development of venous thromboembolism (VTE) in patients with end-stage knee …
    490. The Use of Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) in Atrial Fibrillation
    491. Molecular Mechanism of Anti-cancer Action of PUFAs with Particular Reference to GLA in Glioma
    492. The effects of polyunsaturated fatty acids (PUFAs) on the sleep parameters of the rat pups.
    493. Conditional ablation of retinal ELOVL4 reveals a key role in synthesis of VLC-PUFAs and photoreceptor light responses
    494. Long-chain omega-3 PUFAs and their role in healthy ageing
    495. PC59 DIETARY INTAKE IN PREGNANT WOMEN INFLUENCES PLASMA PHOSPHOLIPIDS LC-PUFAs IN THEIR NEONATES
    496. 310 Relationship between concentrations of omega-3 PUFAs with apolipoproteins in the Cree population from the James bay territories, Québec, Canada
    497. Lipid profile of the yolk under the influence of supplementaries sources rich in Ω-3 PUFAs in the diet of laying hens in the time.
    498. Review on the Regulatory Mechanisms of n-3 PUFAs on Lipid Metabolism and Inflammation-immunity
    499. Study on the extraction of PUFAs from Laminaria japonica with supercritical CO_2
    500. Metabolic and Metabolomic Insights Regarding the Omega-3 PUFAs Intake in Type 1 Diabetes Mellitus
    501. Optimization of Polyunsaturated Fatty Acids (PUFAs) Production from Olive Cake by Pseudomonas fluorescens NBRC14160 using Response Surface Methodology …
    502. NAT–2. Report# 1: High HDL and Low PUFAs Levels in Exudative AMD Patients
    503. P5379 Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular-and all-cause mortality in chronic haemodialysis patients
    504. Role of n-3 PUFAs in inflammation via resolvin biosynthesis
    505. Research Progress on Fungi Mutation Breeding for Producing PUFAs
    506. The Balance of n6/n3 Polyunsaturated Fatty Acid (PUFAs) is an Important Determinant Factor of Prognosis after Acute Myocardial Infarction
    507. Oxidative Stress and Inflammatory Factors in Lung Cancer: Role of n-3 PUFAs
    508. ω-3 PUFAs and Other Cancers
    509. Despite higher n‐6 PUFAs, butter remains a reliable source of saturated fats across the world
    510. Efficacy of omega-3 PUFAs in depression: A meta-analysis
    511. The Determination of ω-Fatty Acids (PUFAs) Effect on caspase-8 gene expression of stomach in patients infected with H. pylori
    512. … of PUFA-rich dietary supplements from marine sources in the feed of laying hens on lipid composition and the percentage of incorporation of n-3 PUFAs in egg yolk.
    513. The construction of pichia pastoris to produce polyunsa turated fatty acids (PUFAs)
    514. The Urgent Need to Re-Think Outside the” Omega-3 PUFAs” Box
    515. … (3-Hydroxy, 3-Methylglutaryl-CoA Reductase) Activity of Cultured Rat Brain Cells: Sensitivity to n-3 and n-6 Polyunsaturated Fatty Acids (PUFAs) from Cod-Liver and …
    516. A study on correlation coefficients between fatty acids in the meat of chickens fed fatty acids (PUFAs) rich diets
    517. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids (PUFAs) in the secondary prevention after myocardial infarction (MI).
    518. Does the intake of LC-PUFAs during pregnancy affect the body composition of term neonates? Preliminary results
    519. 1742-P: Blockade and Reversal of Autoimmunity and Type 1 Diabetes through Gene-Therapeutic and Nutritional Intervention of Elevating ω-3 PUFAs
    520. Healthy polyunsaturated fatty acids (PUFAs) for food enrichment.
    521. 5-Lipoxygenase Mediates The Anti-angiogenic Effects Of-3 PUFAs In Proliferative Retinopathy
    522. The influence of ω-3 PUFAs on chemo-or radiation therapy for cancer
    523. Effect of Omega 3 Polyunsaturated Fatty Acids (PUFAs) on Markers of Inflammation in Young Horses in Training
    524. Conversion of n-3 polyunsaturated fatty acids (PUFAs) and incorporation of docosahexaenoic acid (DHA) in cultured neural cells
    525. Contribution of Dietary PUFAs and Micronutrients in the Protection against Food Allergy Development
    526. Gene Expression Analysis Of Retinas From-3-PUFAs And-6-PUFAs Fed Mice In Oxygen-induced Retinopathy (OIR) Model
    527. Plasma n-3 PUFAs, Cognitive Decline, and White Matter Mediation (P02. 058)
    528. A study on the accumulation of omega-3 PUFAs in egg yolk
    529. Cytochrome P450‐Derived Epoxy Lipids of N‐3 PUFAs Protect the Heart From Ischemia‐Reperfusion Injury by Regulating Mitochondrial Sirtuin 3
    530. Biotechnology for a Sustainable Aquaculture: Selection of Safe Marine Bacteria Producers of LC-PUFAs and Antimicrobials
    531. … role in extending lifespan and reproductive capacity in White Leghorn laying hens; and the effect of polyunsaturated fatty acids (PUFAs) on lipid metabolism …
    532. Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Early-Screening Platform of Anti-Arrhythmic Effects by PUFAs
    533. Polyunsaturated fatty acids (PUFAs) differentially affected abca1-mediated cholesterol efflux from cholesterol-loaded mouse or human macrophages
    534. Omega-3 PUFAs in children with ADHD
    535. … AND N-3/N-6 PUFAs MEMBRANE ABNORMALITIES IN PATIENTS WITH SCHIZOPHRENIA ARE NOT ASSOCIATED WITH SERUM N-3/N-6 PUFAs
    536. Potential and Enzymatic Characterizations of Marine Yeast for PUFAs from Balai Taman Nasional Karimunjawa
    537. The effects of Omega-3, Omega-6 Polyunsaturated Fatty Acids (PUFAs) and Vitamin E on patients with the remitting-relapsing (RR) form of Multiple Sclerosis (MS) in …
    538. New pharmaceutical insights related to the pathways of PUFAs.
    539. Endocannabinoids derived from n-3 PUFAs-Formation, release and possible roles in inflammation and obesity
    540. Comparison Study on the Relative Rates in Heat-Driven Oxidation of PUFAs
    541. Alpha-lipoic acid prevents n-3 PUFAs induced suppression of wound healing
    542. n-3 PUFAs as Modulators of Stem Cells in Prevention of Colorectal Cancer
    543. Biomass production and fatty acids long chain polyunsaturated omega 3 (LC-PUFAs) Chilean strain using thraustochytrids
    544. From arthritis to omega—PUFAs regulate OA in obesity
    545. THU0279 POLYUNSATURATED FATTY ACIDS (PUFAs) AND SPECIALIZED PRO-RESOLVING MEDIATORS (SPMS) ARE DECREASED IN PLASMA AND SERUM …
    546. Supplementation of Omega-3 PUFAs could improve long term prognosis after pci in patients without hyperlipidemia and diabetes
    547. Reactive aldehydes formed from peroxidation of n‐6 and n‐3 PUFAs have differential effects on mitochondrial function in heart
    548. Effects of n-3 PUFAs on depression induced by chronic mild stress in adult male pups experienced maternal separation at early life
    549. THE DOSE-DEPENDENT EFFECTS OF DIFFERENT PUFAs ON ADIPONECTIN AND PPAR γ EXPRESSIONS IN ADIPOCYTES
    550. Is the vascular TREK-1 potentially involved in PUFAs-induced neuronal activation
    551. Abstract A111: Endogenous conversion of n-6 PUFAs to n-3 PUFAs prevents progression of K-Ras activated pancreatic lesion development to pancreatic ductal …
    552. nJ3 PUFAs in cancer, surgery, and critical care: a systematic review on clinical effects, incorporation, and washout of oral or enteral compared with parenteral …
    553. Omega‐3 polyunsaturated fatty acids (n‐3 PUFAs) improve survival following myocardial infarction and inhibit phenylephrine‐induced hypertrophy by regulating …
    554. Morakot Tanticharoen Published: Fungal Genetic and Biology, Vol. 37, No. 1, October 2002, pp. 13-21 Polyunsaturated fatty acids (PUFAs), namely, oleic (C18: l) …
    555. Dietary n-3 PUFAs affect the mRNA expression of satiety regulators in diet-induced obese mice
    556. The influence of combined buckwheat D-fagomine and fish omega-3 PUFAs on beneficial gut bacteria in rats
    557. Determination of expression of regulatory cells of cell cycle S phase in patients with gastric adenocarcinoma with oral administration of PUFAs before and after …
    558. PUFAs Attenuate Blood Lipids and LPS-Inducible Inflammation and ER stress in Adipocyte Tissue in ob/ob Mice
    559. Absorption and Delivery of Synthetic VLC-PUFAs to Mouse Retina
    560. … of Long-chain Polyunsaturated Fatty Acids (LC-PUFAs) in Serum, RBC and Fat with Very-long-chain Polyunsaturated Fatty Acids (VLC-PUFAs) in Human Retina
    561. P2-250 Omega 3 polyunsaturated fatty acids (PUFAs) and risk of early onset prostate cancer
    562. Dietary n-3 PUFAs affect the blood pressure rise and the cardiac function modulation in a hyperinsulinemia rat model in vivo
    563. The Effect of Omega-3 PUFAs on Enterobacter aerogenes
    564. Differences in the Biosynthesis of Long Chain Omega‐3 and Omega‐6 Polyunsaturated fatty acids (PUFAs) between African and European American patients with …
    565. Effects of n-3, n-6 PUFAs and their derivatives on KV7. 1/KCNE1 channels
    566. OMEGA-3 PUFAs IMPROVED ENDOTHELIAL FUNCTION AND LEFT VENTRICLE GLOBAL LONGITUDINAL STRAIN IN PATIENTS WITH SYSTOLIC HEART …
    567. 3 Polyunsaturated fatty acids (PUFAs) and specialized pro-resolving mediators (SPMs) are decreased in plasma and serum from SLE patients compared to healthy …
    568. Screening of high-yield PUFAs Mortierella isabellina strain
    569. STUDY ON THE FERMENTAION FACTORS ON PRODUCTION OF PUFAs BY FERMENTATION USING MONOBLEPHARIS POLYMORPHA CORNU AG
    570. Lack of n3 VLC-PUFAs and Elovanoids correlates with impaired photoreceptor disk morphogenesis in AdipoR1 KO
    571. Marine microalgae PUFAs and synthetase genes application in tumor prevention and treatment
    572. An Approach for Examining the Impact of Food Group‐Based Sources of Nutrients on Outcomes with Application to PUFAs and LDL
    573. Anticancer effect of PUFAs is mediated by inhibition of polyisoprenylated methylated protein methyl esterase
    574. Association between cognitive function and supplementation with omega-3 PUFAs and other nutrients in≥ 75 years old patients: A randomized multicenter study
    575. Correlation of LC-PUFAs in serum with VLC-PUFAs and n3/n6 VLC-PUFA ratios in human donor retinas
    576. Abnormal adipocyte-derived hormones in Rett syndrome mirroring chronic oxidative stress and inflammation: effects of ω-3 PUFAs
    577. Phosphatidylcholine (PC) molecular species-containing very long chain polyunsaturated fatty acids (VLC-PUFAs) are altered in AMD
    578. Targeted and untargeted lipidomics of oxygenated metabolites of PUFAs: a new frontier in health and disease
    579. Reduced Levels Of VLC-PUFAs Lead To Structural And Functional Changes In Rod But Not Cone Photoreceptors
    580. LC-PUFAs: Their roles in neuro-behavioural development and outcomes
    581. Influence of ω-3 PUFAs on predictors of sudden cardiac death in patients with Q-wave myocardial infarction
    582. Significance of VLC-PUFAs in Diabetic Retinas Shown in Mouse and Human Donor Eyes
    583. Eualuation of the efficacy of a dietary supplement containing polyunsaturated fatty acids (PUFAs) and uitamins in the management of dermatitis
    584. EVALUATION OF INHIBITORY POTENTIAL OF PUFAs FROM FISH OIL AGAINST MONOAMINE OXIDASE-B: A MOLECULAR DOCKING STUDY
    585. Omega-3 PUFAs and major depressive disorder
    586. Very long chain polyunsaturated fatty acids (VLC-PUFAs) in cone-and rod-rich regions of the human retina
    587. Effects of Polyunsaturated Fatty Acids (PUFAs) on Global DNA Methylation in Liver of Rats
    588. Effects of isomaltulose and high amounts of PUFAs together with elevated physical activity on subjects with a moderate metabolic risk profile before and after a 6 …
    589. Omega-3 PUFAs in patients with ischaemic heart failure
    590. Dietary Omega-3 PUFAs: In Behavior, Brain Development, and Gut Microbes
    591. Chicken Embryonic Retina as a Model for Studying the Influence of Diet on VLC-PUFAs During Development.
    592. ω-3 PUFAs ARE EFFECTIVE AGAINST WEIGHT LOSS IN CACHECTIC CANCER PATIENTS
    593. Mechanism Action of n-3 PUFAs
    594. Characterization of Diverse Fish Species as Sources of PUFAs and Omega-3 According to Their Fatty Acid Profile
    595. COX-2 Expression and Opposite Growth Effects of N-3 and N-6 PUFAs in Three Novel Pancreatic Adenocarcinoma Cell Lines
    596. Effects of Feeding EFFSB on the Content of PUFAs and CLA of Tissue of Milking Cows
    597. Abstract MP21: No Significant Association of n-3 polyunsaturated Fatty Acids (PUFAs) with T-helper Type 1 (Th1) Cells: Results From the Multi-Ethnic Study of …
    598. The role of Omega-3 PUFAs in treating the symptoms associated with schizophrenia
    599. Dietary Supplementation with Long Chain (LC) PUFAs (n-3, n-6) in Malnourished Children with Chronic Diarrhea
    600. Effects of FADS2 Inhibition in Combination with Increased Dietary n‐3 PUFAs on Skeletal Muscle Protein Turnover in Mice Fed a High Fat Diet.
    601. EFFECT OF VARYING RATIOS OF N3/N6 PUFAs ON THE GROWTH PERFORMANCES OF WHITE INDIAN PRAWN (PENAEUS INDICUS, MILINE, EDWARDS) IN …
    602. Interventional Treatment With 3-PUFAs in the Proliferative Stage of Retinopathy Attenuates Pathologic Neovascularization Through Activation of Ppar
    603. Association of Dietary Intake and RBC Biomarkers of Omega-3 PUFAs with Psychological Wellbeing Among Homeless Youth
    604. n‐3 PUFAs reorganize B cell membrane rafts and molecular order accompanied by differential effects on B cell function
    605. Polyunsaturated Fatty Acids (PUFAs) Inhibit Polyisoprenylated Methylated Protein Methyl Esterase (PMPMEase)
    606. Focus on omega-3 PUFAs in heart failure: your life and your heart
    607. Heterogeneous effect of n-3 polyunsaturated fatty acids (PUFAs) on LDL in vitro oxidation in healthy subjects
    608. Polyunsaturated fatty acids (PUFAs) alter the epigenetic landscape in MDA-MB-231 triple negative breast carcinoma (TNBC)
    609. PUFAs in clinical practice
    610. Dietary PUFAs Enhance Macrophage Autophagy, Attenuate NLRP3 Inflammasome Activation, and Reduce Atherosclerosis
    611. P1137 DIETARY INTAKE IN PREGNANT WOMEN INFLUENCES PLASMA PHOSPHOLIPIDS LC-PUFAs IN THEIR NEONATES
    612. LC-PUFAs: THEIR ROLE IN MATERNAL AND INFANT NUTRITION
    613. Plasma n‐3/n‐6 PUFAs interact with FADS2 genetic variations to affect blood cholesterol concentrations in type 2 diabetes
    614. No Significant Association of n-3 polyunsaturated Fatty Acids (PUFAs) with T-helper Type 1 (Th1) Cells: Results From the Multi-Ethnic Study of Atherosclerosis (MESA)
    615. Evaluation of Various Culture Conditions for the Production of Poly Unsaturated Fatty Acids (PUFAs) from selected Marine Micro-Algae.
    616. Research on extracting PUFAs out of Laminaria japonica by means of supercritical carbon dioxide extraction
    617. Retina Phosphatidyl Choline Molecular Species Containing DHA and VLC-PUFAs Display Cell-selective Decreases in AdipoR1 Conditional KOs
    618. The effects of different fatty acids on the expression of genes related to the synthesis of PUFAs.
    619. Recent Development in the microalgal production of omega-3, omega-6 acids and PUFAs
    620. Optimization of Extraction Technique of PUFAs from the Head of Oratosquilla De Haan by Response Surface Analysis
    621. Omega‐3 Polyunsaturated Fatty Acids (n‐3 PUFAs) Decrease Growth and microRNA‐21 Expression of Estrogen Receptor‐Positive (ER+) MCF‐7 Breast Cancer Cells
    622. Long chian PUFAs omega-3 incorporation in cell membrane microdomains of breast cancer cells
    623. Effect of n-3 PUFAs on arterial stiffness in patients with cardiovascular disease
    624. PUFAs, A Dietary Supplement and Seizure Threshold
    625. A comparison of the effects of free and microencapsulated omega-3 PUFAs on early colorectal cancer biomarkers in the azoxymethane animal model
    626. Dietary Supplementation With Long Chain Poliinsaturated Fatty Acids (Lc-PUFAs) and Recovery of Malnourished Children With Chronic Diarrhea
    627. Effect of dietary PUFAs and vitamin E on allergic responses to peanut in a murine food allergy model
    628. Adiponectin receptor 1 (AdipoR1) is necessary for the synthesis of very long chain polyunsaturated fatty acids (VLC-PUFAs) in Photoreceptor Cells
    629. A comparative study of PUFAs in Algae and higher plants
    630. Kid goat adipose deposits composition in response to maternal intake of a protected fat rich in PUFAs
    631. Neuro-Preventive Effect and Elevation of Cellular Adenosine Triphosphate by PUFAs from Pteleiosis suberosa Stem Bark on Mercury Sub-Acute Exposed …
    632. Administration of alpha-Lipoic Acid Overcomes Detrimental Effects of n-3 PUFAs on Wound Healing in Rat
    633. Response to the Letter of Hester Den Ruijter and Ruben Coronel Regarding the Article” The Role of n-3 PUFAs in Preventing the Arrhythmic Risk in Patients with …
    634. Nutritional modulation of cardiotoxicity and anti‐cancer efficacy related to doxorubicin chemotherapy by glutamine and n‐3 PUFAs (123.8)
    635. OMEGA-3 PUFAs improved endothelial dysfunction and arterial stiffness with a parallel antioxidant effect in patients with metabolic syndrome
    636. … sources of supplementaries PUFAs in the diet of laying hens: effect on lipid composition of the plasma and of the egg yolk and time of incorporation of omega 6 PUFAs …
    637. EFFECTS OF POLYUNSATURATED FATTY ACIDS (PUFAs) ON GLOBAL DNA METHYLATION IN LIVER OF RATS
    638. Dietary Long‐chain PUFAs Enrich Porcine Alveolar Macrophages and Alter Prostaglandin E2 Production Following LPS Challenge
    639. PUFAs emerge as potential treatments for psychiatric disorders
    640. Risk of Parkinson’s Disease (PD) Associated with the Herbicide Paraquat Is Attenuated by High Dietary Intake of Polyunsaturated Fatty Acids (PUFAs)(S42. 004)
    641. Effect of polyunsaturated fatty acids (PUFAs) on the proliferation and extracellular matrix mineralization and gene expression of gilthead seabream skeletal cell lines
    642. Hypertension, cardiac hypertrophy and heart failure: Is there a role for n-3 PUFAs?
    643. Characterization of polyunsaturated fatty acids (PUFAs) in tropical species of fish
    644. Effects of omega-3 PUFAs on activity of NO-system after myocardial ischemia/reperfusion
    645. EFFECT OF DIETARY N-6 POLYUNSATURATED FATTY ACIDS (PUFAs) ON PROSTAGLANDINS (PG) PRODUCED BY MATERNAL INTERCOTYLEDONARY …
    646. Lactobacillus Plantarum Biocenol™ LP96 and n-3 PUFAs and their Immunomodulatory Action.
    647. Novel Role of PUFAs as Essential Cofactors for TRPV4 Function
    648. Effects of fed diets with a different n-6/n-3 PUFAs ratio on oxidative stability, and physico-chemical properties of chickens meat.
    649. Effect of selenium yeast in containing PUFAs dietary on fatty acid composition and antioxidant capacity of Hu lambs.
    650. A meta-analysis is suited to nullify the effects of n–3 PUFAs on cognitive function
    651. ADDITIONAL STUDIES ON THE EFFECT OF N-3 PUFAs ON MACROPHAGE RECRUITMENT AND CHOLESTEROL ACCUMULATION
    652. Inhibitory Effects of Omega-3 PUFAs on Cardiac Fibrosis In Vivo and In Vitro
    653. Effect of n-3 PUFAs in LPS-induced substantia nigra dopaminergic neurons injury
    654. 1TA3-08 Effects of disruption of lipid rafts by PUFAs on T cell recognition (The 47th Annual Meeting of the Biophysical Society of Japan)
    655. The association of ADHD with deficits in fatty acids (FA) and the effect of dietary supplement of n-3 PUFAs on RBC membrane FA profile in children with ADHD.
    656. EFFECT OF HEAT PROCESSING TREATMENTS ON OMEGA-3 POLYUNSATURATED FATTY ACIDS (PUFAs) IN FISH
    657. Effect of ω-3 PUFAs on regulation of Toll-like receptor 4 and nuclear factor-ΚB signaling pathway in neonatal rats with brain injury induced by LPS
    658. Effects of endogenous omega-3 polyunsaturated fatty acids (PUFAs) on psoriatic lesion and Th17 cells in IMQ-induced psoriasis-like model.
    659. Evaluation the Effect of Oral Administer PUFAs on Apoptosis in Gastric Mucosa in Patients Infected with Helicobacter Pylori
    660. Western diets high in N-6 polyunsturates (PUFAs) may increase the risk of premature birth.
    661. … that certain polyunsaturated fatty acids (PUFAs) exert cytotoxic actions for cancer cells in vitro and in vivo without affecting normal cells. Administration of PUFAs …
    662. Heavy metal effects on types and levels of Omega-3 polyunsaturated fatty acids (PUFAs) in Tilapia Fish (Oreochromis niloticus) in Winam gulf of Lake Victoria
    663. Effect of ω-3 PUFAs on the retinal neovascularrization.
    664. The Association Between Erythrocyte n-3 Polyunsaturated Fatty Acids (n-3 PUFAs) Content and Inflammation in Male Patients With Peripheral Artery Disease …
    665. Conditional Depletion of Retinal VLC-PUFAs Causes Retinal Dysfunction
    666. Egg design–new formulation by enrichment of PUFAs using natural substances
    667. Cultivation of PUFAs producing Sicyoidochytrium minutum strain using by-products from agriculture
    668. Effect of n-3 PUFAs on mental and retina disease in middle-aged and elderly
    669. Investigation of the Hydrolysis Characteristics for Increasing of PUFAs from Fish Oil by Lipolase-100T
    670. Influence of omega-3 PUFAs on the metabolism of proanthocyanidins in rats
    671. Metabolomic approach to the nutraceutical effect of rosemary extract plus omega-3 PUFAs in diabetic children with capillary electrophoresis.
    672. ω-3 PUFAs and Cachexia
    673. n-3 PUFAs and reperfusion injury in isolated cardiomyocytes
    674. A Single Mediterranean-Type Meal Leads to Postprandial Enrichment in Omega-3 PUFAs and Does Not Impair Flow-Mediated Dilatation in Comparison to a High …
    675. Effects of Different PUFAs Supplementation During the Postpartum Periods of Early Lactating Dairy Cows, I: Uterine Prostaglandin Synthesis.
    676. Factors influencing the effects of dietary supplementation with PUFAs on leukotriene generation by leucocytes in patients with asthma
    677. Efficiency of the use of polyunsaturated fatty acids (PUFAs) in treatment of cerebral atherosclerosis
    678. Effects of Different PUFAs Supplementation on Uterine Gene Expression During the Postpartum Periods of Early Lactating Dairy Cows.
    679. Study on antiadipogenic effects of omega n-3 polyunsaturated fatty acids (PUFAs) in vitro on adipocytes differentiated from bone marrow mesenchymal stem cells …
    680. Biosynthesis of C22-polyunsaturated fatty acids (PUFAs) in the moss physcomitrella patens by the algae paviova sp. 5-elongasa
    681. ω-3 PUFAs and Breast Cancer: Epidemiological Studies
    682. STUDIES O OPTIMIZATIO OF FERME TATIO PARAMETER FOR PUFAs PRODUCTIO
    683. Behavioral Resiliency of Mice to Repeated Mild Cerebral Concussion: Are there Interactions with Dietary Polyunsaturated Fatty Acids (PUFAs)?
    684. PUFAs mediate the COX-1 inflammatory pathway, a potential target for the treatment of epithelial ovarian cancer
    685. Children with autism: A pilot treatment trial with fishoil EPA/DHA. Evaluation of symptom change and changes in PUFAs after supplementation–a randomised double …
    686. Pulsed-Field Gel Analysis of Thraustochytrium aureum and Process for Targeting of Gene Involved in PUFAs Biosynthesis
    687. P0167 PP N-3 LC-PUFAs IN HUMAN COLOSTRUM MILK AND TH1/TH2-RELATED MRNA LEVELS IN CORD AND MATERNAL BLOOD
    688. Dynamic interactions between G proteins and plasma membrane nanodomains: Effects of antidepressants and PUFAs
    689. ω-3 PUFAs in the Prevention and Cure of Inflammatory, Degenerative, and Neoplastic Diseases
    690. SUMMARY Macronutrient study for PUFAs production from tiie marine microalga Isochrysis galbana
    691. 1P-195 Effects of disruption of lipid rafts by PUFAs on T cell recognition (Biol & Artifi memb.: Signal transduction, The 47th Annual Meeting of the Biophysical Society of …

     

    Share
    0
    INTERSTELLAR BLEND

    Related posts

    May 20, 2022

    EXTENDS LIFESPAN


    Read more
    May 20, 2022

    MENAQUINONE 4


    Read more
    May 20, 2022

    SHBG


    Read more

    Comments are closed.

    Recent Posts

    • EXTENDS LIFESPAN
    • MENAQUINONE 4
    • SHBG
    • STAR PROTEIN
    • STEM CELL REGENERATION
    © 2022 Interstellar Blends | Activate Your Super Powers!. © 2019 Interstellar Blends | Activate Your Super Powers!. All Rights Reserved.

    Mandatory FDA Disclaimer
    Privacy Policy
    Terms and Conditions
    Have Questions?
    Contact Gavin Robert McGowen Here

    Join the following facebook groups to learn more:
    Ultimate Weightloss Challenge , Dry Fasting, Longevity Agents , Interstellar Blend Seven Sages, The Infinitely Postive, THE INTERSTELLAR BLEND CHALLENGE: Fluid Restricted Fasting w/ Superherbs

    Love this Website? Contact David Rodriguez to build you one!